$2.70
0.13[5.06%]
Last update: 10:47AM Get Real Time Here
VYNE Therapeutics
(NASDAQ:VYNE)VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary
VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.
| Open | $2.520 |
| Close | - |
| Volume / Avg. | 53.468K / 107.523K |
| Day Range | 2.410 - 2.800 |
| 52 Wk Range | 1.670 - 8.730 |
| Market Cap | $38.067M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 52 |
| Short Interest | 0.61% |
| Days to Cover | 1 |
Recent News
No news found
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About VYNE Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative a...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy VYNE Therapeutics (VYNE) stock?
You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.
Who are VYNE Therapeutics's (VYNE) competitors?
Other companies in VYNE Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC) and Jaguar Health (NASDAQ:JAGX).
What is the target price for VYNE Therapeutics (VYNE) stock?
The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Thursday, February 29, 2024. The analyst firm set a price target for 5.75 expecting VYNE to rise to within 12 months (a possible 112.26% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for VYNE Therapeutics (VYNE)?
The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $2.7089 last updated April 24, 2024 at 4:32 PM EDT.
Does VYNE Therapeutics (VYNE) pay a dividend?
There are no upcoming dividends for VYNE Therapeutics.
When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?
VYNE Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
Is VYNE Therapeutics (VYNE) going to split?
There is no upcoming split for VYNE Therapeutics.
What sector and industry does VYNE Therapeutics (VYNE) operate in?
VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.